Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 30, 2024
IL15 and IL21: Better When Membrane-Tethered Together on Antitumor T CellsAyana T Ruffin, Megen C Wittling, Anna C Cole, et al.
Frontiers in Immunology|February 5, 2021
Shared and Unique Features of Human Interferon-Beta and Interferon-Alpha SubtypesMegen C Wittling, Shannon R Cahalan, Eric A Levenson, et al.
Cancers|August 29, 2024
Strategies for Improving CAR T Cell Persistence in Solid TumorsMegen C Wittling, Anna C Cole, Brianna Brammer, et al.
Biorxiv : the Preprint Server for Biology|January 8, 2024
Distinct host preconditioning regimens differentially impact the antitumor potency of adoptively transferred Th17 cellsMegen C Wittling, Hannah M Knochelmann, Megan M Wyatt, et al.
Journal for Immunotherapy of Cancer|June 30, 2024
Distinct host preconditioning regimens differentially impact the antitumor potency of adoptively transferred Th17 cellsMegen C Wittling, Hannah M Knochelmann, Megan M Wyatt, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 19, 2025
Development of a murine tumor-infiltrating lymphocyte therapy model for cholangiocarcinomaMegen C Wittling, Frances J Bennett, Emilie A K Warren, et al.
Journal for Immunotherapy of Cancer|August 25, 2025
Constructing the cure: engineering the next wave of antibody and cellular immune therapiesStefanie R Bailey, Eric Bartee, Kyle G Daniels, et al.
Cancer Research|July 6, 2026
TLR9 Agonists Potentiate Adoptive T Cell Therapy in Cancer through a B Cell-CD2 Costimulatory AxisAyana T Ruffin, Vasili Toliopoulos, Aubrey S Smith, et al.
Cancer Cell|July 25, 2025
Adoptively transferred Th17 cells cooperate with host B cells to achieve durable tumor immunityAnna C Cole, Hannah M Knochelmann, Megan M Wyatt, et al.
Pageof 2